Cannabis Law Report

NOVEMBER 1, 2021

billion by 2025 1. Curaleaf International’s cannabis flower products and extracted cannabis-based products now supply five separate markets, including Germany, Europe’s largest market for medicinal cannabis which is expected to be worth over €840 million by 2025 1. billion by 2025 1. billion by 2025 1.

Seed-To-Sale 52

Seed-To-Sale Supply Chain Medicine Research and Development 52

Cannabis Law Report

NOVEMBER 28, 2021

Medical cannabis business Equinox International is planning to list on the London Stock Exchange to raise cash for a ‘state-of-the-art’ cultivation, extraction and production facility on a Home Office-approved 20-acre UK site. UK medical cannabis market to have addressable market of £7.5bn by 2028 .

Research and Development 52

Research and Development Business Cultivation Access 52

Cannabis Law Report

JANUARY 12, 2020

It has approved use of cannabis extracts for treatment of a range of illnesses and conditions, including cancer, epilepsy, Alzheimer’s, Parkinson’s disease and anxiety. The Government has promised to open more clinics in greater Bangkok, with patients able to book appointments via a specialised smartphone app.

Research and Development 59

Research and Development Marijuana Agriculture Medicine 59

Cannabis Law Report

JUNE 7, 2021

According to Prohibition Partners, active patients grew by approximately 17% from 2019 to 2020, reaching over 70,000 patients, leading to imports into Israel of over 7 tonnes by July 2020. 230 million by 2025. “We The Israeli medical cannabis market was characterized by strong year-over-year growth in 2020. d/b/a “ JWC ”).

Cultivation 100

Cultivation Recreational Cannabis Events 100

Cannabis Law Report

SEPTEMBER 15, 2021

Total retail sales in Missouri are expected to grow to USD$650 million by 2025 per New Frontier Data. The state of Missouri surpassed 100,000 patients in May 2021 (seven months after the first sale) and robust patient adoption trends have continued since. market in Missouri. market in Missouri. expansion.”.

Events 52

Events Dispensary Extraction Cannabis 52

Cannabis Law Report

AUGUST 24, 2021

Hoshi will use commercially reasonable efforts to grant Flora access to its European Union Good Manufacturing Practices (“EU-GMP”) auditors for the purposes of assisting Flora to obtain EU-GMP certification at its Cosechemos cultivation and extraction facility in Colombia. billion by 2025. billion by 2025. “We of the market.

Events 105

Events Cultivation Access Business 105

Cannabis Law Report

FEBRUARY 18, 2020

Researchers predict that the market will be valued at $7 billion by the year 2025. And according to a Nielsen analytical report , the US market of legal marijuana will reach $41 billion in revenue by 2025, meaning that New York will make up close to 17% of the market share. patient application. billion in revenue.

Marijuana 59

Marijuana Consumption Dispensary Vaping 59

Cannabis Law Report

JULY 15, 2022

“It’s very important from our perspective to ensure that the Australian patient gets medicine first. The first medicinal cannabis ‘mother’ plants are expected to be imported from Israel within a month, with manufacturing scheduled to begin within the first half of this year, to supply 5,000 Australian patients.

Medicine 52

Medicine Patients Media Supply Chain 52

Cannabis Law Report

JULY 26, 2019

The Australian cannabis market is expected to have a net worth of approximately $55 million by the end of 2025. AGH is in the process of buying a Canadian recreational cannabis company, Peak Processing Solutions, which is focussed on the extraction, production and processing of edibles, drinks and cosmetics imbibed with cannabis.

Banking 45

Banking Medicine Research and Development Recreational 45

Cannabis Law Report

OCTOBER 17, 2019

Plants with higher THC levels are typically bred and consumed for medical or adult recreational purposes, either in dried form for smoking or with the THC content extracted and infused into foods, beverages, topical ointments, candles, and other products. billion in 2025, according to Grandview Research.

Law 40

Law Seed-To-Sale Hemp Recreational 40

Cannabis Law Report

MAY 19, 2019

Cannabis plant or its resin or extract with THC content lower than 1% is considered as CBD (medical) cannabis and not psychoactive. billion dollars by 2025. Ingesting cannabis helps lower the pressure in the eyeball, giving patients at least temporary relief. Economic benefits of Marijuana: Thailand as a Case Study.

Legalization 45

Legalization Seed-To-Sale Marijuana Decriminalization 45

Cannabis Law Report

SEPTEMBER 21, 2022

The continued strength of the Company’s medical adjusted gross margins 1 reflect the direct-to-patient model in Canada and sustained presence in the high margin international medical business. CBD extract sales, cannabis net revenue was $51.2 Consolidated: Q4 2022 total cannabis net revenue 1 was $50.2

Research and Development 52

Research and Development Cannabis Data Events 52